Archives for August 16, 2005

← 2005

Revolutionary diabetes R&D drives Biovitrum deal

By  Wai Lang Chu

Biovitrum and Santhera have announced the signing of an exclusive license and collaboration agreement, which aims to develop DPP-IV inhibitors for the treatment of type 2 diabetes and other metabolic diseases.

Vicuron approves Pfizer merger

By  Wai Lang Chu

Vicuron Pharmaceuticals announced that its stockholders have voted to approve the merger agreement with the world's biggest drug maker Pfizer.

Contract manufacturing news in brief

Who's making what for whom? In-PharmaTechnologist provides its periodic round-up of new deals and developments in the pharmaceutical contract manufacturing sector.

End of the line looms for Able Laboratories

By Phil Taylor

Troubled generic drug manufacturer Able Laboratories has conceded defeat in its bid to get products back onto the market and elected to sell off the assets of the business.